"We are very pleased and proud to be a sponsor of this important new conference," said Jeb Besser, CEO of Modular Medical. "The conference mission aligns closely with our corporate vision to ...

Participants with nephrotic syndrome in NEPTUNE Match will receive information about the PIONEER study and other clinical trials based on their individual disease characteristics;PIONEER study expands ...

RadNet posted Q3 2024 revenue of $461.1 million, beating estimates. Digital Health revenue rose 34.3%, driving growth in AI ...

Chris Caldwell, President and CEO of Concentrix, to discuss AI's transformative impact on the customer experienceCompany to showcase leading-edge technologies at Stand 0404-16, FIL1 Pavilion 1 NEWARK ...

Next June, Gartner will succeed Lanny McDonald as Hall of Fame chairman, the latter’s 10-year term coming to an end at that ...

Roche’s Genentech is ending a partnership with Nykode Therapeutics that centered around a clinical-stage cancer vaccine ...

Bill Presley, Vice-Chairman and COO of Aptiv PLCto become President and CEO, and Board Director, as of January 1, 2025Phil Eyler to Remain as an ...

Ricks is being recognized for his contributions to Indiana’s life sciences sector and his global impact on health care ...

Collegium Pharmaceutical said it named Vikram Karnani as chief executive, effective Nov. 12. The specialty pharmaceutical company on Thursday said that Karnani, who will also be joining the board, ...

Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...

Moderna's Spikevax COVID vaccine brought in sales of $1.8 billion, up 3.5% over the previous year and handily beating analysts' average expectations of $1.38 billion. The company said it benefited ...

An influx of late-phase programs has prompted Genmab to reassess its bets. | An influx of late-phase programs has prompted Genmab to reassess its bets. The biotech is axing three early-stage clinical ...